All Business articles – Page 8
View all stories with this category.
-
BusinessAkzoNobel sells off specialty chemicals arm in €10bn deal
Private equity firm Carlyle sees off several other bidders
-
-
Business
Fit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
News
Brexit analysis predicts chemical industry contraction
UK government forced to publish briefing that suggests production will fall by up to 16%
-
Business
US steel and aluminium tariffs threaten chemical and plastics sectors
Trump administration to levy 25% tariff on steel and 10% on aluminium
-
Business
Battery builders get the cobalt blues
Demand for battery metals surges on the back of a global appetite for electric vehicles
-
Business
Outline for Europe’s first waste to methanol plant
Enerkem teams up with AkzoNobel and Air Liquide to turn rubbish into raw materials
-
Business
Indian court seizes former Ranbaxy owners’ assets
Daiichi Sankyo inches closer to recovering money from Singh brothers
-
Business
DowDupont names its three new separate businesses
Corteva Agriscience, Dow and DuPont will be what DowDuPont calls the three independent companies it will spin-off by June 2019
-
Business
Takata settles with US states over faulty airbag inflators
States will forgo the $650m civil penalty in favour of victims
-
Business
Company profile: Ellutia
Ellutia takes GC beyond the ‘box-in-the-lab’, with its customised chromatography
-
Business
Chemist caught stealing and dumping cyanide
Merck & Co senior analytical chemist arrested for stealing and then dumping highly toxic substance down a curbside drain
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
-
Business
Sanofi enters M&A bonanza
French drugmaker strengthens rare diseases portfolio with blood disorder purchases
-
News
Apotex chief executive steps down amid tumult at generics firm
President and chief executive of Canada’s biggest generic drugmaker resigns the same day that police announce its founder and his wife were murdered
-
Business
Celgene takes a punt on M&A
Cancer specialist bags Juno therapeutics and Impact Biomedicines
-
Business
FDA new drug approvals more than doubled in 2017
The FDA approved 46 new drugs last year – the highest number in over two decades – due to factors like streamlined policies at the agency
-
Business
Non-profit generic drug company created
Intermountain Healthcare is leading an effort in the US to prevent drug shortages and end their skyrocketing prices
-
Business
Dementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
